Literature DB >> 7116644

Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium.

J F Lenney, R P George, A M Weiss, C M Kucera, P W Chan, G S Rinzler.   

Abstract

Human serum carnosinase was assayed using a simple and sensitive fluorometric method. Under optimum conditions, the average adult serum hydrolyzed 42 mu mol of carnosine per ml per hour, about 17 times the average activity reported in the literature. Cadmium was twice as effective as manganese as an activator of this enzyme. Serum carnosinase was found to be different in many respects from cellular carnosinase. For example, the serum isozyme hydrolyzed homocarnosine, whereas the cellular carnosinase did not. The apparent molecular weight of serum carnosinase was 160 000, while that of the cellular isozyme was 90 000. Although it has been reported that serum contains two molecular forms of carnosinase, only one form was detected using several electrophoretic methods and two ion exchange chromatography procedures. The concentration of serum carnosinase varied greatly between individuals. Little or no enzyme was detected in children below 10 months in age. Thereafter, the average concentration of carnosinase increased gradually to reach the adult range at age 13-15.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7116644     DOI: 10.1016/0009-8981(82)90166-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  23 in total

1.  CNDP1 knockout in zebrafish alters the amino acid metabolism, restrains weight gain, but does not protect from diabetic complications.

Authors:  Felix Schmöhl; Verena Peters; Claus Peter Schmitt; Gernot Poschet; Michael Büttner; Xiaogang Li; Tim Weigand; Tanja Poth; Nadine Volk; Jakob Morgenstern; Thomas Fleming; Peter P Nawroth; Jens Kroll
Journal:  Cell Mol Life Sci       Date:  2019-05-09       Impact factor: 9.261

Review 2.  Carnosine and Related Peptides: Therapeutic Potential in Age-Related Disorders.

Authors:  José H Cararo; Emilio L Streck; Patricia F Schuck; Gustavo da C Ferreira
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

3.  Inherited differences in mouse kidney carnosinase activity.

Authors:  F L Margolis; M Grillo
Journal:  Biochem Genet       Date:  1984-06       Impact factor: 1.890

4.  N-glycosylation of carnosinase influences protein secretion and enzyme activity: implications for hyperglycemia.

Authors:  Eva Riedl; Hannes Koeppel; Frederick Pfister; Verena Peters; Sibylle Sauerhoefer; Paula Sternik; Paul Brinkkoetter; Hanswalter Zentgraf; Gerjan Navis; Robert H Henning; Jacob Van Den Born; Stephan J L Bakker; Bart Janssen; Fokko J van der Woude; Benito A Yard
Journal:  Diabetes       Date:  2010-05-11       Impact factor: 9.461

Review 5.  Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery.

Authors:  J P Bai; G L Amidon
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

6.  Differential neuroprotective effects of carnosine, anserine, and N-acetyl carnosine against permanent focal ischemia.

Authors:  Jiangyong Min; Marie-Claude Senut; Krishnamurthy Rajanikant; Eric Greenberg; Ram Bandagi; Daniel Zemke; Ahmad Mousa; Mounzer Kassab; Muhammad U Farooq; Rishi Gupta; Arshad Majid
Journal:  J Neurosci Res       Date:  2008-10       Impact factor: 4.164

7.  Carnosine synthase deficiency is compatible with normal skeletal muscle and olfactory function but causes reduced olfactory sensitivity in aging mice.

Authors:  Lihua Wang-Eckhardt; Asisa Bastian; Tobias Bruegmann; Philipp Sasse; Matthias Eckhardt
Journal:  J Biol Chem       Date:  2020-10-09       Impact factor: 5.157

8.  Characterization of human tissue carnosinase.

Authors:  J F Lenney; S C Peppers; C M Kucera-Orallo; R P George
Journal:  Biochem J       Date:  1985-06-15       Impact factor: 3.857

9.  Biological activity of novel synthetic derivatives of carnosine.

Authors:  S L Stvolinsky; E R Bulygina; T N Fedorova; K Meguro; T Sato; O V Tyulina; H Abe; A A Boldyrev
Journal:  Cell Mol Neurobiol       Date:  2009-10-02       Impact factor: 5.046

10.  Transport and distribution of homocarnosine after intracerebroventricular and intravenous injection in the rat.

Authors:  O Ziesler; K Hole; I Haugan; A L Børresen; L R Gjessing; O Sjaastad
Journal:  Neurochem Res       Date:  1984-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.